欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0118/003
药品名称Vaxar 600 mg
活性成分
    • Grepafloxacin hydrochloride sesquihydrate 0.0 [no unit]
剂型[not specified]
上市许可持有人Glaxo Wellcome GmbH & Co. Industriestr. 32-36 D-23834 Bad Oldesloe
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
许可日期1997/11/09
最近更新日期2024/05/28
药物ATC编码
    • A ALIMENTARY TRACT AND METABOLISM
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase